Group A Streptococcal Meningitis in a Healthy Child: A Case Report Highlighting Diagnostic and Therapeutic Challenges

Authors

  • Ema Freitas Pediatric Department, Unidade Local de Saúde de São José, Hospital Dona Estefânia; Child and Adolescent Intermediate Care Unit, Hospital Cuf Descobertas https://orcid.org/0009-0008-1884-1090
  • Clara Picão de Carvalho Child and Adolescent Intermediate Care Unit, Hospital Cuf Descobertas; Pediatric Department, Unidade Local de Saúde de Santa Maria
  • Mariana Nogueira Child and Adolescent Intermediate Care Unit, Hospital Cuf Descobertas https://orcid.org/0000-0002-9997-570X
  • Isabel Esteves Pediatric Infectious Diseases Department, Hospital Cuf Descobertas https://orcid.org/0000-0001-6162-259X
  • Hugo de Castro Faria Child and Adolescent Intermediate Care Unit, Hospital Cuf Descobertas https://orcid.org/0000-0001-9250-2734

DOI:

https://doi.org/10.25753/BirthGrowthMJ.v35.i3.42397

Keywords:

drug-induced fever, group A Streptococcus bacterial meningitis, penicillin

Abstract

Group A streptococci commonly causes non-invasive infections like tonsillitis and skin infections, but rarely causes invasive infections, such as bacteraemia and meningitis. Invasive streptococcal disease increased in Europe in 2022 and 2023, but rates returned to prepandemic levels in 2024. GAS meningitis remains rare. This case highlights a 13-month-old healthy child with fever, irritability alternating with periods of prostration, and petechial rash, diagnosed with Group A streptococcal meningitis. She was treated initially with ceftriaxone and vancomycin and later with penicillin based on culture results. Despite clinical and analytical improvement, persistent fever prompted further investigations, ruling out complications or other infections. The fever resolved after switching to ceftriaxone, suggesting drug-induced fever due to penicillin hypersensitivity. No neurological sequelae were detected in this case. Although rare, Group A streptococcal meningitis poses significant risks of morbidity and mortality, emphasising the need for prompt recognition and appropriate treatment.

Downloads

Download data is not yet available.

References

Mercadante S, Ficari A, Romani L, Maia De Luca, Costanza Tripiciano, Chiurchiù S, et al. The Thousand Faces of Invasive Group A Streptococcal Infections: Update on Epidemiology, Symptoms, and Therapy. Children (Basel). 2024;11(4):383.

Stevens DL, Kaplan SL. Invasive group A streptococcal infections in children, Jun 2025 (Accessed June 16, 2025). Available at: https://www.uptodate.com/contents/invasive-group-a-streptococcal-infections-in-children.

Lee J, Blackburn J, Pham-Huy A. Uncommon clinical presentation of a common bug: Group A Streptococcus meningitis. Paediatrics & Child Health. 2020 May 28;26(3):e129–31.

Link-Gelles R, Toews KA, Schaffner W, Edwards KM, Wright C, Beall B, et al. Characteristics of Intracranial Group A Streptococcal Infections in US Children, 1997–2014. J Pediatric Infect Dis Soc. 2020; 9(1):30-35.

Fanella S, Embreé J. Group A Streptococcal Meningitis in a Pediatric Patient. Canadian Journal of Infectious Diseases & Medical Microbiology. 2008 Jan 1;19(4):306–8.

Perera N, Abulhoul L, Green M, Swann R. Group A streptococcal meningitis: case report and review of the literature. Journal of Infection. 2005 Aug;51(2):E1–4.

Torres L, Rodrigues AM, Francisco C, Santos S, Carvalho P. Streptococcus pyogenes Meningitis in a Pediatric Patient: Case Report. Acta médica portuguesa. 2023 Jul 5; 37(2):142-4. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/19941.

Arnoni MV, Berezin EN, Sáfadi MAP, Almeida FJ, Lopes CRC. Streptococcus pyogenes meningitis in children: report of two cases and literature review. The Brazilian journal of infectious diseases. 2007 Jun 1;11(3):375–7.

Baraldés MA, Domingo P, Mauri A, Monmany J, Castellanos M, Pericas R, et al. Group A Streptococcal Meningitis in the Antibiotic Era. European Journal of Clinical Microbiology & Infectious Diseases. 1999 Sep 2;18(8):572–8.

Sullins AK, Abdel-Rahman SM. Pharmacokinetics of Antibacterial Agents in the CSF of Children and Adolescents. Pediatric Drugs. 2013 Mar 26;15(2):93–117.

Haddad N, Carr M, Balian S, Lannin J, Kim Y, Toth C, et al. The Blood–Brain Barrier and Pharmacokinetic/Pharmacodynamic Optimization of Antibiotics for the Treatment of Central Nervous System Infections in Adults. Antibiotics [Internet]. 2022 Dec 1;11(12):1843. Available from: https://www.mdpi.com/2079-6382/11/12/1843.

Zitteren van, Arents NL, Halbertsma F. Group-A-streptococcal meningitis in a 7-year-old child - a rare pathogen in a non-immune compromised patient. BMJ case reports. 2011 Nov 21;2011(nov17 1):bcr1020114896–6.

Cunha B. Antibiotic Essentials Fourteenth Edition [Internet]. Available from: https://rudiapt.wordpress.com/wp-content/uploads/2017/08/antibiotic-essentials-14th-ed-2015.pdf.

Long SS, Prober CG, Fischer M. Principles and practice of pediatric infectious diseases. 5th ed. Philadelphia, Pa: Elsevier; 2018.

Downloads

Published

2026-10-12

How to Cite

1.
Freitas E, Picão de Carvalho C, Nogueira M, Esteves I, de Castro Faria H. Group A Streptococcal Meningitis in a Healthy Child: A Case Report Highlighting Diagnostic and Therapeutic Challenges. BGMJ [Internet]. 2026 Oct. 12 [cited 2026 Oct. 15];35(3):147-50. Available from: https://revistas.rcaap.pt/bgmj/article/view/42397

Issue

Section

Clinical Case Reports